High Cholesterol Completed Phase 2 Trials for Ezetimibe (DB00973)

Also known as: High Blood Cholesterol Level / Hypercholesterolemia / Hypercholesteremia / Hypercholesterolaemia / Congenital xanthoma / Hypercholesteraemia / Elevated cholesterol

IndicationStatusPhase
DBCOND0037835 (High Cholesterol)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02890992An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaTreatment
NCT01941836Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsTreatment
NCT02055976Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese SubjectsTreatment
NCT03051100Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CTreatment
NCT00405067The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate HypercholesterolemiaTreatment
NCT00440154A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate HypercholesterolemiaTreatment
NCT00677248LDL-Cholesterol Lowering Effect of KB2115 as Add on to EzetimibeTreatment